21 May 2013
Keywords: vyortin, reduces, apo-b, crp, levels, study, drugmakers
Article | 18 September 2006
US drugmakers Merck & Co and Schering-Plough say that data from two clinical studies show that Vyortin (ezetimibe/simvastatin) reduces the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 September 2006
20 May 2013
© 2013 thepharmaletter.com